-+ 0.00%
-+ 0.00%
-+ 0.00%

ABL Texcell Diagnostics Ends Proposed Acquisition of Vela's US, Singapore Operations

MT Newswires·10/21/2026 00:40:27
Listen to the news
12:40 AM EDT, 10/21/2026 (MT Newswires) -- ABL Texcell Diagnostics (ABLD.PA) terminated its letter of intent to acquire Vela Diagnostics' operations in the US and Singapore, ending the proposed transaction. The molecular diagnostics company said Tuesday that the nonbinding LoI, announced Sept. 21, covered the acquisition of 100% of the share capital of Vela Operations Singapore and Vela Diagnostics USA.